The Valley Desk

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisPublished

Real-World Assessment of All-Cause Hospital Readmissions among Pulmonary Embolism Patients Treated With Rivaroxaban Versus Apixaban

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published
Subject terms
Humans; Pulmonary Embolism; Pyrazoles; Pyridones; Patient Readmission; Retrospective Studies; Aged; Middle Aged; Female; Male; Factor Xa Inhibitors; Rivaroxaban
PubMed ID
40129292
PubMed Central ID
PMC11938890
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal